Compare Mondaycom Ltd (MNDY) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mondaycom Ltd vs ResMed Inc. — how do they compare? Mondaycom Ltd trades at $81.4 (market cap $3.43B), while ResMed Inc. trades at $219.5 (market cap $31.73B). The key difference: ResMed Inc. is far larger — about 9.3× Mondaycom Ltd's market cap, and ResMed Inc. pays a 1.2% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.
| MNDY | RMD | |
|---|---|---|
Market Cap | $3.43B | $31.73B |
Sector | Technology | Health |
52-Week High | $219.15 | $283.28 |
52-Week Low | $58.81 | $182.82 |
Enterprise Value | $2.59B | $31.08B |
Dividend Yield | — | 1.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNDY trades at $83.67, down 8.13% over 24 hours, with a bearish technical signal but strong fundamentals including 88.74% gross margins and consecutive earnings beats. Revenue grew to $1.23B in 2025, though net cash flow turned negative in 2026. Recent news highlights inclusion in growth stock lists and AI-driven monetization gains.
Outlook is mixed: analyst consensus is bullish with a $106 price target, but technical weakness and negative cash flow trends pose risks. The stock offers growth potential from operational efficiency and market positioning, yet investors face volatility from competitive pressures and execution challenges.
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
